Status:
ACTIVE_NOT_RECRUITING
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
Lead Sponsor:
Russian Cardiology Research and Production Center
Conditions:
Idiopathic Pulmonary Arterial Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This study will be performed based on a retrospective analysis of the cases of 150-170 patients with IPAH observed at the Research Institute of Clinical Cardiology over the past 10 years, for a compar...
Eligibility Criteria
Inclusion
- age over 18 years;
- verified diagnosis of IPAH
Exclusion
- age under 18 years;
- Other etiology op PAH,
- ischemic heart disease confirmed by MSCT of the coronary arteries or coronary angiography;
- diseases of the musculoskeletal system that prevent 6MWT
- severe liver dysfunction (more than 9 points on the Child-Pugh scale, class C)
- severe renal dysfunction (CC less than 15 ml/min), need for hemodialysis
Key Trial Info
Start Date :
May 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06587074
Start Date
May 30 2023
End Date
July 22 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Russian National Cardilogy Reasearch Center
Moscow, Russia, 121552